PrEP

PrEP in 2025: Bridging the Gap Between Innovation and Access

The global HIV response stands at a crossroads. Pre-exposure prophylaxis (PrEP)—one of the most effective tools in HIV prevention—has achieved remarkable scientific progress, yet access remains deeply inequitable and is now at a heightened threat to further be underfunded or not funded at all. By the end of 2024, approximately 8 million people had initiated

A New Tool to Keep Breastfeeding Moms Safe from HIV Infection

Mother breastfeeding a baby in Kenya 2016.

A recent article in The Lancet HIV describes results of a study on the safety of the dapivirine vaginal ring for preventing HIV in breastfeeding mothers—and consequently protecting their babies, as well. We recently spoke with lead author Dr. Lisa Noguchi, Jhpiego’s Director for Maternal and Newborn Health, about the real-life implications of these findings.